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The acidic tail of a-synuclein (ATSa) has been shown to
protect the glutathione S-transferase (GST)±ATSa fusion
protein from environmental stresses, such as heat, pH and
metal ions. In this study, we further demonstrated that the
introduction of ATSa into other proteins, such as dehy-
drofolate reductase and adiponectin, renders the fusion
proteins resistant to heat-induced aggregation and that the
acidic tail of b- or g-synuclein can also protect the fusion
proteins from heat-induced aggregation. Interestingly, the
heat resistance of GST±ATSa deletion mutants, which
contain shorter peptides derived from the highly charged
regions of ATSa, was approximately proportional to the
number of added Glu/Asp residues. However, the negative
charges in the ATSa-derived peptides appear insuf®cient
to explain the extreme heat resistance of the fusion
proteins, since polyglutamates appeared to be much less
effective than the ATSa-derived peptides in conferring
heat resistance on the fusion proteins. These results sug-
gest that not only the negatively charged residues but also
the speci®c amino acid sequence of ATSa play an import-
ant role in conferring extreme heat resistance on the
fusion proteins. Furthermore, the heat-induced secondary
structural changes and thermal inactivation curves of
GST±ATSa deletion mutants indicated that the introduc-
tion of ATSa-derived peptides does not signi®cantly affect
the intrinsic stability of the fusion proteins.
Keywords: fusion protein/heat-resistant proteins/protein
aggregation/protein stability/a-synuclein
Introduction
Protein aggregation is a complex phenomenon that can occur
both in vivo and in vitro, usually resulting in the irreversible
loss of the protein's biological activity (Cleland et al., 1993;
Speed et al., 1995, 1996; Carpenter et al., 1999). In many
cases, protein aggregation in vivo leads to protein deposition
diseases. For example, it has been suggested that many
neurological disorders, such as Alzheimer's disease,
Parkinson's disease, Huntington's disease and prion disease,
are caused by the abnormal aggregation and deposition of Ab,
a-synuclein, huntingtin and prion, respectively (Tan and Pepys
1994; Speed et al., 1996; Serpell et al., 1997; Cohen, 1999;
Lansbury, 1999; Lucking and Brice, 2000; Ghiso and
Frangione, 2002; Ross, 2002). Protein aggregation in vitro,
which occurs even under conditions favoring the native state,
leads to major economic and technical problems in the
biotechnology and biopharmaceutical industries. In particular,
the overexpression of some eukaryotic proteins in heterologous
hosts results in the formation of inclusion bodies (Williams
et al., 1982; Hlodan et al., 1991; Kane and Hartley, 1991;
Jaenicke, 1995). These inclusion bodies have to undergo a
refolding process to recover their biological activity. However,
the process of renaturation is frequently dif®cult and the
ef®ciency is very low, as a result of protein aggregation during
the in vitro refolding processes. Moreover, the soluble
recombinant proteins also aggregate frequently during the
puri®cation, storage and handling process in the presence of
chemical, physical and thermal stresses (Manning et al., 1989;
Cleland et al., 1993; Fink, 1998; Przybycien, 1998).
Protein aggregation is a major problem, particularly in the
biomedical and biopharmaceutical ®elds (Cleland et al., 1993;
Carpenter et al., 1999). In addition to eliminating or reducing
the protein's therapeutic ef®cacy and shelf-life, the aggregation
of parenterally administrated proteins can cause adverse
patient reactions, such as an unwarranted immune response,
hypersensitization or even anaphylactic shock (Moore et al.,
1980; Robbins et al., 1987; Ratner et al., 1990; Thornton and
Ballow, 1993; Braun et al., 1997). Therefore, it is essential that
aggregate formation should be prevented during all stages of
product handling. For this reason, many researchers have been
trying to overcome protein aggregation problems (Manning
et al., 1989; Carpenter et al., 1999; Talaga, 2001; Horwich,
2002; Schlieker et al., 2002). Usually, therapeutic proteins are
protected against potential stresses by the addition of proper
excipients or additives. In addition, chemical modi®cation and
site-directed mutagenesis of proteins are often adopted to
produce a more stable form.
In a previous report, we demonstrated that the introduction
of the C-terminal acidic tail of a-synuclein (ATSa) into a heat-
labile protein, glutathione S-transferase (GST), protects the
fusion protein from heat-induced aggregation (Park et al.,
2002a). Furthermore, ATSa appears to protect the fusion
protein from pH- and metal-induced protein aggregation,
suggesting that the acidic tail can increase the virtual stability
of the protein by protecting it from the aggregation induced by
environmental stresses (Park et al., 2002a). In an extension of
this study, we systematically investigated the effects of novel
peptides derived from the C-terminal acidic tails of synuclein




Glutathione (GSH), dithiothreitol (DTT), 1-chloro-2,4-dinitro-
benzene (CDNB) and isopropyl-b-D-thiogalactopyranoside
(IPTG) were purchased from Sigma (St Louis, MO).
Glutathione-Sepharose 4B was obtained from Peptron
(Taejon, Korea) and Ni-NTA resin from Invitrogen
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(Carlsbad, CA). Leupeptin, pepstatin, phenylmethylsulfonyl
¯uoride (PMSF) and imidazole were purchased from
Boehringer Manheim (Mannheim, Germany).
Preparation of dihydrofolate reductase (DHFR)±ATSa fusion
protein
DHFR and DHFR±ATSa fusion protein were prepared as
described previously (Park et al., 2002b).
Preparation of adiponectin and adiponectin±ATSa fusion
protein
Adiponectin expression vector was produced by subcloning the
globular domain of mouse adiponectin gene (residues 111±
247) (Scherer et al., 1995) into the pRSETA vector.
Adiponectin±ATSa fusion construct was produced by con-
secutively subcloning the globular domain of mouse adipo-
nectin gene and the C-terminal acidic tail of a-synuclein
(ATSa, residues 96±140) (Ueda et al., 1993; Jakes et al., 1994)
into the pRSETA vector. Both constructs were veri®ed by
DNA sequencing.
The adiponectin and adiponectin±ATSa expression vectors
were transformed into the Escherichia coli strain BL21 (DE3)
for protein expression. One liter of bacteria carrying the
recombinant plasmids was grown from a single colony at 25°C
in LB medium containing 100 mg/ml ampicillin and 0.5%
lactose. After overnight culture, bacteria were harvested by
centrifugation. The recombinant adiponectin and adiponectin±
ATSa fusion protein were puri®ed by conventional column
chromatographic techniques. The bacterial pellet was disrupted
by sonication at 4°C in a lysis buffer containing 20 mM Tris±
HCl, pH 7.5, 1 mM EDTA, 0.002% PMSF and 20 mg/ml
leupeptin. The homogenate was then centrifuged for 10 min at
4°C at 10 000 r.p.m. The supernatant was loaded on to a
DEAE-Sepharose CL 6B column, which was pre-equilibrated
with 20 mM Tris±HCl buffer, pH 7.5, containing 0.1 M NaCl
and 1 mM EDTA. The column was washed with the same
buffer and the bound proteins were eluted from the column by a
linear gradient from 0.1 to 0.4 M NaCl in 20 mM Tris±HCl
buffer, pH 7.5. The eluted adiponectin fractions were pooled
and concentrated and were further puri®ed on an FPLC gel-
®ltration column equilibrated in 20 mM phosphate-buffered
saline (PBS), pH 7.5.
Preparation of GST±ATSb and GST±ATSg fusion proteins
GST±ATSb and GST±ATSg fusion constructs were generated
by subcloning the acidic tail of b-synuclein (ATSb, residues
85±134) (Jakes et al., 1994) and the acidic tail of g-synuclein
(ATSg, residues 96±127) (Ji et al., 1997), respectively, into
pGEX vector (Pharmacia Biotech, Buckinghamshire, UK). The
protein coding region of the ATSb was ampli®ed by PCR with
the 5¢-oligonucleotide primer AGCTAAGGATCCAAGA-
GGGAGGAATTCC containing the underlined BamHI restric-
tion site and the 3¢-oligonucleotide primer AAGTAA-
CTCGAGCTACGCCTCTGGCTCATA containing the under-
lined XhoI restriction site. The protein coding region of the
ATSg was ampli®ed by PCR with the 5¢-oligonucleotide primer
AAGAATGGATCCCGCAAGGAGGACTTGA containing
the underlined BamHI restriction site and the 3¢-oligonucleo-
tide primer AATAGCGAATTCCTAGTCTCCCCCACTCT
containing the underlined EcoRI restriction site. The ampli®ed
DNAs were gel puri®ed, digested with appropriate enzymes,
then ligated into the pGEX vector that had been digested with
appropriate restriction enzymes and gel puri®ed. All constructs
(pGST-ATSb and pGST-ATSg) were veri®ed by DNA
sequencing. The GST±synuclein fusion constructs,
pGST-ATSb and pGST-ATSg, were transformed into the
E.coli strain, BL21 (DE3) and the recombinant GST±synuclein
fusion proteins (GST±ATSb and GST±ATSg) were puri®ed by
af®nity chromatography using glutathione-Sepharose 4B
beads. The GST±synuclein fusion proteins were further
puri®ed on an FPLC gel-®ltration column pre-equilibrated
with PBS, pH 7.4.
Deletion mutant forms of the GST±ATSa fusion protein
The DNAs encoding the parts of the acidic tail of a-synuclein
(ATSa) were chemically synthesized (Table I). Using these
synthetic cDNAs, a series of GST±ATSa deletion constructs
were generated by ligating the parts of the ATSa gene into
pGEX vector using the BamHI and EcoRI restriction sites.
GST±Syn103±115 contains 13 amino acids of the ATSa
(residues 103±115), GST±Syn114±126 contains 13 amino
acids of the ATSa (residues 114±126), GST±Syn119±140
contains 22 amino acids of the ATSa (residues 119±140)
and GST±Syn130±140 contains 11 amino acids of the
ATSa (residues 130±140) (Table I). All constructs




Syn103±115 S 5¢-gatccaatgaagaaggagccccacaggaaggcattctggaagattaag-3¢ NEEGAPQEGILED
AS 5¢-aattcttaatcttccagaatgccttcctgtggggctccttcttcattg-3¢







Syn130±140 S 5¢-gatccgaggaagggtatcaagactacgaacctgaagcctaag-3¢ EEGYQDYEPEA
AS 5¢-aattcttaggcttcaggttcgtagtcttgatacccttcctcg-3¢
E5 S 5¢-gatccgaagaagaagaagaataag-3¢ EEEEE
AS 5¢-aattcttattcttcttcttcttcg-3¢






































and pGST-Syn130±140) were veri®ed by DNA sequencing.
The GST±ATSa deletion constructs, pGST-Syn103±115,
pGST-Syn114±126, pGST-Syn119±140 and pGST-Syn130±
140, were transformed into the E.coli strain BL21 (DE3)
and the recombinant proteins were puri®ed by af®nity
chromatography using glutathione-Sepharose 4B beads.
The GST±ATSa deletion mutants were further puri®ed
on an FPLC gel-®ltration column pre-equilibrated with PBS,
pH 7.4.
Preparation of GST±polyE fusion proteins
The DNAs encoding the polyglutamates (pentamer and
decamer, E5 and E10, respectively) were chemically synthe-
sized (Table I). Using these synthetic cDNAs, GST±polyE
fusion constructs were generated by ligating the annealed
oligonucleotides into pGEX vector using the BamHI and EcoRI
restriction sites. All constructs were veri®ed by DNA
sequencing. The GST±polyE fusion proteins were puri®ed by
af®nity chromatography using glutathione-Sepharose 4B beads
as described above.
Heat-induced protein aggregation assay
The heat-induced aggregation of GST fusion proteins was
qualitatively assayed by SDS±PAGE after heat treating the
protein samples. Each protein in PBS (0.8 mg/ml) was heated
in a boiling water-bath for 10 min and then cooled in the open
air. The protein samples were centrifuged at 15 000 r.p.m. for
10 min and the supernatants were analyzed on a 12% SDS±
polyacrylamide gel. The level of heat-induced aggregation of
GST fusion proteins was also quantitatively measured by
monitoring the apparent absorbance (scattering) at 360 nm as a
function of time at 65°C (Horwitz, 1992; Lee and Vierling,
1998; Kim et al., 2000a; Uversky et al., 2001; Park et al.,
2002a). Each protein was diluted to a ®nal concentration of
0.2 mg/ml in the PBS buffer. The protein sample in the
spectrophotometric cuvette was placed in a thermostatic
cell holder and the apparent absorbance was monitored
in a Beckman DU-650 spectrophotometer. Finally, the
concentration-dependent protein aggregation of the GST
fusion proteins was quantitatively assayed by monitoring
their absorbance at 360 nm, while varying the concentra-
tion from 0.2 to 1.0 mg/ml after heat treatment at 80°C for
5 min.
Circular dichroism (CD) measurements
The CD spectra were recorded on a Jasco (Japan) J715
spectropolarimeter equipped with a temperature control system
in continuous mode as described previously (Kim et al., 2000b;
Park et al., 2002a). Far-UV CD measurements were carried out
over the wavelength range 190±250 nm with 0.5 nm band-
width, a 1 s response time and a 10 nm/min scan speed at 25
and 95°C. The spectra shown are an average of ®ve scans that
were corrected by subtraction of the buffer signal. Thermal
denaturation experiments were performed using a heating rate
of 1°C/min and a response time of 1 s. The CD spectra were
measured every 0.5°C at a wavelength of 222 nm.
GST activity assay
The enzymatic activity of GST was assayed using a
chromogenic substrate, 1-chloro-2,4-dinitrobenzene (CDNB),
as described previously (Habig et al., 1974; Park et al., 2002a).
Results
Heat resistance of DHFR±ATSa and adiponectin±ATSa
fusion proteins
Introducing the acidic tail of a-synuclein (ATSa, residues 96±
140; also called Syn96±140) into GST appeared to protect the
fusion protein from environmental stresses, such as heat, pH
and metal ions (Park et al., 2002a). To investigate whether
ATSa can be utilized to suppress the aggregation of other
proteins, we ®rst produced a DHFR±ATSa fusion protein and
compared the thermal behaviors of DHFR and the DHFR±
ATSa fusion protein using a qualitative heat-induced protein
aggregation assay. Each protein was heat-treated in a water
bath at 65 or 100°C for 10 min and the protein solution was
centrifuged to remove the precipitates. Subsequently, the
supernatant was analyzed on an SDS±polyacrylamide gel
Fig. 1. Thermal behaviors of DHFR±ATSa and adiponectin±ATSa fusion
proteins. (A) Heat resistance of the DHFR±ATSa fusion protein. The DHFR
and DHFR±ATSa fusion proteins (0.6 mg/ml of each protein in PBS) were
incubated for 10 min at room temperature (RT), 65°C and 100°C,
respectively. The protein solutions were centrifuged and the supernatants
were analyzed on a 12% SDS±polyacrylamide gel. The protein bands were
stained with Coomassie Brilliant Blue R-250. (B) Heat resistance of the
adiponectin±ATSa fusion protein. The adiponectin and adiponectin±ATSa
fusion proteins (1.0 mg/ml of each protein in PBS) were incubated for 10
min at various temperatures and monitored on a spectrophotometer.































(Figure 1A). As expected, DHFR±ATSa did not precipitate on
heat treatment up to 100°C, whereas the DHFR protein
completely precipitated at 65°C. We next produced a
recombinant adiponectin and adiponectin±ATSa fusion
protein and compared the heat resistance by monitoring the
absorbance at 405 nm as a function of incubation temperature,
while setting the concentration of each protein sample at
1.0 mg/ml. As shown in Figure 1B, the introduction of ATSa
into the adiponectin appeared to protect the fusion protein
signi®cantly from heat-induced aggregation, when it was
detected on a spectrophotometer. These results indicate that
ATSa is a novel peptide conferring heat resistance on the
fusion proteins.
Heat resistance of the GST±synuclein fusion protein
containing the C-terminal acidic tail of b-synuclein or
g-synuclein
In addition to a-synuclein, b- and g-synucleins and synoretin,
which belong to the synuclein family, have also been identi®ed
in humans (Ueda et al., 1993; Jakes et al., 1994; Ji et al., 1997;
Surguchov et al., 1999). The N-terminal amphipathic regions
of the synuclein family members are well conserved among the
species, but the C-terminal acidic tails are very diverse in size
and in sequence (Lavedan, 1998; Hashimoto and Masliah,
1999; Iwai, 2000; LuÈcking and Brice, 2000). We next
investigated whether GST±ATSb and GST±ATSg fusion
proteins containing the acidic tail of b-synuclein (ATSb,
residues 85±134) and that of g-synuclein (ATSg, residues 96±
127), respectively, are resistant to heat-induced aggregation
(Figure 2A). GST±ATSb and GST±ATSg fusion proteins were
qualitatively examined for heat resistance by SDS±PAGE, as
described previously (Park et al., 2002a). As shown in
Figure 2B, GST±ATSb and GST±ATSg as well as GST±
ATSa do not precipitate at all after heat treatment at 100°C for
10 min, which indicates that they are extremely heat resistant.
Subsequently, the thermal behaviors of the GST±ATS fusion
proteins were quantitatively compared by monitoring their
absorbance at 360 nm over time, while setting the concentra-
tion of each protein at 0.2 mg/ml at 65°C (Horwitz, 1992; Lee
and Vierling, 1998; Kim et al., 2000a; Uversky et al., 2001;
Park et al., 2002a). In this experiment, as shown in Figure 2C,
the GST protein had almost aggregated after 2±3 min. In
contrast, the GST±ATS fusion proteins did not aggregate at all
even 10 min after heat treatment. Next, the GST±ATS fusion
proteins were quantitatively assayed by monitoring the
absorbance at 360 nm while varying the concentration from
0.2 to 1.0 mg/ml after heat treatment at 80°C for 5 min. As
shown in Figure 2D, the GST±ATS fusion proteins did not
precipitate at all after heat treatment, independently of the
concentration, whereas the GST protein was completely
precipitated at a low concentration. These results indicate
that in addition to ATSa, the ATSb and ATSg peptides are also
capable of providing heat resistance to other proteins and they
can be used in the preparation of fusion proteins having
resistance to environmental stresses. Since the amino acid
sequence of synoretin is very similar to that of g-synuclein
Fig. 2. Thermal behavior of GST±ATS fusion proteins. (A) Schematic diagram of GST±ATS fusion proteins. Starting and terminating residue numbers of ATS
peptides are labeled. (B) SDS±PAGE analysis of GST±ATS fusion proteins after boiling for 10 min. (C) Heat-induced aggregation of the GST±ATS fusion
proteins (0.2 mg/ml of each protein in PBS) was quantitatively assessed by monitoring the light scattering (OD360) as a function of time at 65°C. (D) Heat-
induced aggregation of GST±ATS fusion proteins was quantitatively assessed by monitoring the light scattering as a function of protein concentration after
































(Surguchov et al., 1999), the acidic tail of synoretin may have a
similar property.
Heat-resistance of GST±synuclein fusion proteins with
shorter peptide fragments derived from the ATSa
The C-terminal acidic tail of a-synuclein (ATSa) is composed
of 45 amino acids (residues 96±140) and 15 Glu/Asp residues
are scattered throughout the ATSa (Ueda et al., 1993; Jakes
et al., 1994). We next investigated the thermal behaviors of
deletion mutants of the GST±ATSa fusion protein which have
shorter ATSa peptide fragments. For this purpose, a series of
GST±ATSa deletion mutants were produced using peptide
fragments which span the highly charged regions of ATSa
(Figure 3A). GST±Syn103±115 contains ®ve Glu/Asp residues
out of a total of 13 amino acids contained in a fragment of
ATSa (residues 103±115); GST±Syn114±126 contains 6 Glu/
Asp residues out of a total of 13 amino acids contained in a
fragment of ATSa (residues 114±126); GST±Syn119±140
contains nine Glu/Asp residues out of a total of 22 amino acids
contained in a fragment of ATSa (residues 119±140); and
GST±Syn130±140 contains ®ve Glu/Asp residues out of a total
of 11 amino acids contained in a fragment of ATSa (residues
130±140). Isoelectric points (pI) of these fusion proteins are
shown in Table II. When these GST±ATSa deletion mutants
were thermally treated at a high concentration (0.8 mg/ml),
GST±Syn96±140, which contains the entire region of ATSa,
and GST±Syn119±140, which contains 22 amino acids of
ATSa, did not precipitate at all, whereas GST±Syn103±115,
GST±Syn114±126 and GST±Syn130±140, which contain 11±
13 amino acids, precipitated almost completely (Figure 3B).
On the other hand, when these GST±ATSa deletion mutants
Fig. 3. Thermal behavior of GST±ATSa deletion mutants. (A) Schematic diagram of GST±ATSa deletion mutants. See text for details. (B) SDS±PAGE
analysis of GST±ATSa deletion mutants before (above) and after (below) boiling for 10 min. (C) Heat-induced aggregation of the GST±ATSa deletion
mutants (0.2 mg/ml of each protein in PBS) was quantitatively assessed by monitoring the light scattering (OD360) as a function of time at 65°C. (D) Heat-
induced aggregation of the GST±ATSa deletion mutants was quantitatively assessed by monitoring the light scattering as a function of protein concentration
after heating for 5 min at 80°C. (C, D) graphs: 1, GST; 2, GST±Syn103±115; 3, GST±Syn114±126; 4, GST±Syn119±140; 5, GST±Syn130±140; and 6, GST±
Syn96±140.
Table II. Isoelectric point (pI) and the temperature for the onset of
unfolding (Tu) values of GST, GST±ATSa deletion mutants and GST±polyE
fusion proteins
Protein pI value Tu valuea (°C) Heat resistance
GST 6.18 54b _
GST±Syn103±115 5.35 54 ++
GST±Syn114±126 5.26 58 ++
GST±Syn119±140 5.03 58 ++++
GST±Syn130±140 5.35 55 ++
GST±E5 5.38 57 +
GST±E10 5.02 56 ++
GST±ATSa 4.85 54b ++++
GST±ATSb 4.79 NDc ++++
GST±ATSg 5.52 ND ++++
aTu values were obtained by linear extrapolation of the melting curves
(Figure 6) to the temperature axis.
bDetermined from previously reported data (Park et al., 2002a).
cND, not determined.































were thermally treated at a low concentration (0.2 mg/ml),
none of the fusion proteins aggregated (data not shown).
The thermal behaviors of the GST±ATSa deletion mutants
were quantitatively analyzed by monitoring the absorbance at
360 nm over time, while setting the concentration of each
protein at 0.2 mg/ml at 65°C. As shown in Figure 3C, the
OD360 of the GST protein drastically increased 2 min after heat
treatment and most of the protein had aggregated by 3 min. In
contrast, the GST±ATSa deletion mutants did not aggregate at
all even 10 min after heat treatment. Next, the GST±ATSa
deletion mutants were quantitatively assayed by monitoring the
absorbance at 360 nm, while varying the concentration from
0.2 to 1.0 mg/ml after heat treatment at 80°C for 5 min. As
shown in Figure 3D, GST±Syn96±140, which contains the
entire region of ATSa, and GST±Syn119±140, which contains
22 amino acids of ATSa, did not precipitate at all after heat
treatment under these conditions, whereas GST±Syn103±115,
GST±Syn114±126 and GST±Syn130±140, which contain 11±
13 amino acids of ATSa, did not precipitate at a low
concentration, but increasingly aggregated as the concentration
rose. It is well known that the extent of protein aggregation is
proportional to the concentration (Zettlmeissl et al., 1979;
Kiefhaber et al., 1991). Hence it was demonstrated that the
GST±ATSa deletion mutants have heat resistance superior to
that of wild-type GST and, interestingly, that the heat
resistance varies depending on the length and charge density
of ATSa. Therefore, optimum effects can be achieved by
suitably selecting the length and charge density of ATSa
according to the size and hydropathy of the target protein.
Thermal behaviors of GST±polyglutamate fusion proteins
As demonstrated in Figure 3, the heat resistance of the GST±
ATSa deletion mutants appeared to be approximately propor-
tional to the number of Glu/Asp residues in the ATSa
fragments. To address the importance of negative charge in
the process of conferring heat resistance on the fusion proteins,
we next examined whether GST fusion proteins with genuinely
negatively charged peptide fragments such as polyglutamate
are heat resistant. For this, a series of GST±polyglutamate
fusion proteins were constructed by ligating the gene part of
polyglutamate into pGEX vector (Figure 4A). Puri®ed proteins
of GST±E5 (containing ®ve consecutive glutamate residues)
and GST±E10 (containing 10 consecutive glutamate residues)
are demonstrated in Figure 4B and the pI values of these fusion
proteins are shown in Table II. Each protein suspended in PBS
(0.8 mg/ml) was heated in a boiling water-bath for 10 min and
then cooled in air. The protein samples were centrifuged at
15 000 r.p.m. for 10 min and the supernatants were analyzed on
a 12% SDS±polyacrylamide gel. Neither GST±E5 nor GST±
E10 showed any protein bands after heat treatment, which
indicates that they had been completely precipitated by heat
treatment (data not shown). This indicates that, unlike the
GST±ATSa fusion proteins, neither GST±E5 nor GST±E10 is
heat resistant under such stringent conditions.
Fig. 4. Thermal behavior of GST±polyE fusion proteins. (A) Schematic diagram of GST±poly E (E5, E10) fusion proteins. (B) SDS±PAGE of GST, GST±E5
and GST±E10. (C) Heat-induced aggregation of GST, GST±E5 and GST±E10 (0.2 mg/ml of each protein in PBS) was quantitatively assessed by monitoring
the light scattering (OD360) as a function of time at 65°C. (D) Heat-induced aggregation of GST, GST±E5 and GST±E10 was quantitatively assessed by
































The thermal behaviors of the GST±E5 and GST±E10 fusion
proteins were quantitatively assayed by monitoring their
absorbance at 360 nm over time, while setting the concentra-
tion of each protein at 0.2 mg/ml at 65°C. As shown in
Figure 4C, the GST protein was completely aggregated after 2±
3 min and the GST±E5 fusion protein was aggregated to a
considerable extent under the same conditions, whereas the
GST±E10 fusion protein did not aggregate at all under these
conditions. Next, the GST±polyglutamate fusion proteins were
quantitatively assayed by monitoring their absorbance at 360
nm, while varying the concentration from 0.2 to 1.0 mg/ml
after heat treatment at 80°C for 5 min. As shown in Figure 4D,
the GST protein was completely precipitated at a low
concentration and most of the GST±E5 protein was precipi-
tated at a high concentration. In contrast, the GST±E10 protein
was partially precipitated after heat treatment under these
conditions and increasingly aggregated as the concentration
rose. Hence as the length of the polyglutamate increases, the
negative charge considerably increases, thus causing the
amount of aggregation decrease. Interestingly, however, it is
noted that the polyglutamate tail is considerably less effective
in providing heat resistance, as compared with ATS peptides
containing the same number of glutamate residues (Figures 3
and 4; Table II). In fact, GST±Syn130±140 shows heat
resistance far superior to that of GST±E5, which contains the
same number of glutamate residues, and slightly better heat
resistance than that of GST±E10, which contains twice as many
glutamate residues (compare Figure 3D with Figure 4D).
Therefore, it is suggested that the characteristic amino acid
sequence of ATS, in addition to the increased solubility of
the proteins due to the increase in the negative charge, plays
an important role in conferring resistance to heat-induced
aggregation.
CD spectra of GST±Syn119±140 and GST±E10
To address the conformational properties of the introduced
peptide tags, we compared the CD spectra of representing
fusion proteins (Figure 5). The far-UV CD spectra of GST±
Syn119±140 indicate that the protein contains well-ordered
secondary structure elements (absorption bands at 210±220 nm
in Figure 5A). The CD spectrum at room temperature appeared
to be very similar to that of GST (®gure 7A in Park et al.,
2002a). Interestingly, however, the far-UV CD spectra of the
GST±E10 exhibit an additional absorption band at 195 nm,
which is characteristic of random-coiled polypeptides
(Figure 5B). These results suggest that the Syn119±140 peptide
in GST±Syn119±140 may be packed together with the GST
domain, but the E10 peptide in GST±E10 may be extended
from the GST domain to the solvent forming a random-coil
peptide.
Secondary structural changes of GST±ATSa deletion
mutants and GST±polyE fusion proteins
The secondary structural changes of the GST±ATSa deletion
mutants and GST±polyE fusion proteins induced by the
increase of temperature were investigated by CD spectroscopy.
Speci®cally, to compare the thermal stabilities of the fusion
proteins, the thermal unfolding of each protein was monitored
at 222 nm as a function of temperature (Figure 6). Consistent
with a previous report (®gure 7A in Park et al., 2002a), the
temperature-induced unfolding of GST started around 54°C
and the CD signal kept diminishing until 100°C due to the
complete precipitation of the protein (data not shown). Unlike
in the case of wild-type GST protein, however, the tempera-
ture-induced unfolding of the GST±ATSa deletion mutants all
took place in two stages (Figure 6A±D). The ®rst transition
started at ~54±58°C, whereas the second transition occurred at
>90°C. The melting curves of GST±polyE fusion proteins
appeared to be similar to those of the GST±ATSa deletion
mutants (Figure 6E and F), although the secondary transition
was less clearly seen. It is highly likely that the secondary
transition of GST is not able to be observed, since the protein
precipitates before that temperature. Interestingly, the ®rst
transition temperatures of the GST±ATSa deletion mutants
and GST±polyE fusion proteins all appeared to be similar or
slightly higher than that of wild-type GST, suggesting that the
introduced acidic tails do not signi®cantly affect the intrinsic
stability of the protein.
Enzyme activity of GST±ATSa deletion mutants after
heat-treatment
We next compared the thermostability of the GST±ATSa
deletion mutants by measuring their thermal inactivation
curves (Figure 7), which were used to determine the T50
values, i.e. the temperatures at which 50% of the initial
enzymatic activity is lost after heat treatment. As shown in
Figure 7, the T50 values of the GST±ATSa deletion mutants are
only slightly higher than that of wild-type GST. This suggests
that the stabilizing effect of ATSa peptides on the enzymatic
activity is not particularly high, at least in the case of GST.
Discussion
Previous studies have demonstrated that the C-terminal acidic
tail of a-synuclein (ATSa) is capable of protecting the GST±
ATSa fusion protein from stress-induced aggregation (Park
Fig. 5. Far-UV CD spectra of (A) GST±Syn119±140 and (B) GST±E10. Far
UV-CD spectra measured at 25 and 95°C are drawn as solid and dotted
lines, respectively.































et al., 2002a). In this study, we have shown that the
introduction of ATSa into other proteins, such as DHFR and
adiponectin, renders the fusion proteins resistant to heat-
induced aggregation. In addition to ATSa, ATSb and ATSg
also appear to protect the fusion protein from heat-induced
aggregation. These ATS fusion proteins also appear to be
resistant to pH- and metal-induced aggregation (our unpub-
lished results). These results indicate that ATS peptides are
novel peptides, conferring resistance to environmental stresses,
such as heat, pH and metal ions. These results also imply that
many biologically or medically important proteins, particularly
those having aggregation problems, could be transformed into
a more resistant protein by introducing the ATS peptides.
The C-terminal acidic tails of the synuclein family members
are diverse in size and sequence, but they are all highly charged
with many Glu/Asp residues (Lavedan, 1998; Hashimoto and
Masliah, 1999; Iwai, 2000; LuÈcking and Brice, 2000). Earlier
studies have shown that protein solubility is approximately
proportional to the square of the net charge on the protein
Fig. 6. Melting curves of GST±ATSa deletion mutants and GST±polyE fusion proteins. The mean molar ellipticity per residue of each protein (0.4 mg/ml in
PBS) at 222 nm was measured as a function of temperature. The solid lines represent temperature scans from 20 to 100°C (heating mode). (A) GST±Syn103±
115; (B) GST±Syn114±126; (C) GST±Syn119±140; (D) GST±Syn130±140; (E) GST±E5; and (F) GST±E10.
Fig. 7. Thermal inactivation of the GST±ATSa deletion mutants. Activity is
expressed as a percentage of initial activity. Values are the means of three
independent experiments with the standard deviation shown as bars. The

































(Tanford, 1961). Therefore, the abolishment of heat-induced
aggregation in ATS containing fusion proteins at high
temperatures seems to be primarily due to the presence of the
negatively charged residues in the ATS peptides, since these
negative charges increase the solubility of the protein, by
increasing its hydrophilicity and by causing intermolecular
interactions to be unfavorable. This possibility is supported by
the fact that the GST±ATSa deletion mutants, which contain
shorter peptides derived from the highly charged regions of
ATSa, all appear to be relatively heat resistant. In particular,
the heat resistance of the GST±ATSa deletion mutants is
approximately proportional to the number of Glu/Asp residues
in the ATSa fragments in addition to the peptide chain length.
For example, GST±Syn119±140, which contains nine Glu/Asp
residues out of a total of 22 amino acids contained in a
fragment of ATSa, is extremely heat resistant, as in the case of
GST±Syn96±140. In contrast, GST±Syn103±115, GST±
Syn114±126 and GST±Syn130±140, which contain 5±6 Glu/
Asp residues out of a total of 11±13 amino acids contained in a
fragment of ATSa, are less heat resistant. Consequently, the
heat resistance of the GST±ATSa deletion mutants is correl-
ated with their pI values (Table II). These results indicate that
the negative charges contributed by the Glu/Asp residues in the
ATSa-derived peptides are crucial for conferring heat resist-
ance on the fusion proteins.
However, the negative charges in the ATSa-derived
peptides appear insuf®cient to explain the extreme heat
resistance of the fusion proteins. As shown in Figure 4,
GST±E5, which contains ®ve consecutive Glu residues, is
much less heat resistant than GST±Syn130±140 or GST±
Syn103±115, which contain the same number of Glu/Asp
residues. Similarly, GST±E10, which contains 10 consecutive
Glu residues, is much less heat resistant than GST±Syn119±
140, which contains nine Glu/Asp residues. The heat resistance
of GST±E10 is fairly comparable to that of GST±Syn130±140.
These results suggest that not only the charged residues, but
also the speci®c amino acid sequence of ATSa, plays an
important role in conferring extreme heat resistance on the
fusion proteins. It would be interesting to investigate in more
detail just why the ATS peptides fused in GST are superior to
other highly charged peptides for protecting the fusion proteins
from stress-induced aggregation.
To address the above question, we compared the far-UV CD
spectra of GST±Syn119±140 and GST±E10 and found that the
conformations of the introduced peptide tags might be different
(Figure 5). The CD spectra of GST±Syn119±140 and GST±E10
suggest that the Syn119±140 peptide might be packed with the
GST domain in the fusion protein, but the E10 peptide might
protrude from the GST domain, forming an exposed random
coil-like conformation. This re¯ects that, unlike the E10
peptide, Syn119±140 peptide has a potential to interact with
other proteins, as has been implied by previous studies
(reviewed in LuÈcking and Brice, 2000). Presumably, the
hydrophobic residues, which are scattered throughout the ATS,
play an important role in the ATS peptide±protein interactions.
Based on this observation, it is tempting to speculate that the
intramolecular and/or intermolecular peptide±protein inter-
actions mediated by the characteristic amino acid sequence of
ATS peptides play an additional role in conferring the extreme
heat resistance on the fusion proteins.
The effects of ATSa peptides on the stability of the fusion
proteins were assessed by analyzing their heat-induced
secondary structural changes and thermal inactivation curves
(Figures 6 and 7, respectively). To compare the stabilities of
the proteins, it is useful to determine the melting temperature
(Tm) of each protein by CD spectroscopy or calorimetric
analysis. Tm has been widely used as a thermodynamic
parameter of the conformational stability of the protein.
However, Tm can be correctly determined only for the
reversible transition. For the irreversible transition, Tm is
meaningless and often contains numerous errors. For example,
the heat-induced unfolding of GST starts at around 54°C and
the CD signal at 222 nm keeps diminishing until 100°C as the
protein precipitates (Park et al., 2002a). The Tm value
determined from this melting curve cannot but be overesti-
mated. To describe quantitatively the protein stability for the
irreversible transition, we therefore compared the derived
temperatures for the onset of unfolding (Tu values), which were
obtained by linear extrapolation of the melting curves to the
temperature axis (Table II), as previously tried by Chrunyk and
Wetzel to determine the derived temperatures for the onset of
aggregation (Chrunyk and Wetzel, 1993). The Tu values of the
GST±ATSa deletion mutants and GST±polyE fusion proteins
appear to be around 54±58°C (Figure 6; Table II), whereas that
of GST is about 54°C (®gure 7A in Park et al., 2002a). These
results indicate that the introduction of the acidic tails does not
signi®cantly affect the intrinsic stability of the protein. Rather,
they appear to somewhat stabilize the fusion proteins. Analysis
of the thermal inactivation curves results in a similar conclu-
sion (Figure 7). The T50 values, the temperature at which 50%
of the initial enzyme activity is lost after heat treatment, of the
GST±ATSa deletion mutants appear to be very similar to or
slightly higher than that of wild-type GST. These results also
indicate that the introduction of ATSa-derived peptides does
not signi®cantly affect the intrinsic stability of the protein.
In summary, we have demonstrated that the introduction of
the ATS peptides into heat-labile proteins protects the fusion
proteins from heat-induced aggregation. Furthermore, our data
suggest that the ATS peptides do not signi®cantly affect the
intrinsic stability of the fusion proteins. Introducing the ATS
peptides will also contribute to the protein's solubility, since it
greatly increases the hydrophilicity of the protein and makes
intermolecular interactions unfavorable through electrostatic
repulsion. Therefore, the ATS peptides can be utilized to
increase protein solubility and to protect the protein from
environmental stresses. Many biologically or medically
important proteins that have solubility problems or stress-
induced aggregation problems might be saved by introducing
the ATS peptides. Introducing the ATS peptides could make
the protein more robust and enhance its shelf-life and duration
time in vivo. Consequently, introducing the ATS peptides
could also make the protein more amenable to use in
alternative delivery methods and formulations.
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